Results from a nationwide survey on drugs have been released. Commissioned by Bauer Media, the “A Bitter Pill“ survey invited radio listeners to provide details of their habits, thoughts and knowledge of recreational drugs, referring to substances such as ectstacy, PMA and legal highs.
Of the 2,307 respondents, 55% they did not think there was any significant risk in taking “party” drugs on one occasion. Indeed 25% admitted to having tried Ecstasy or MDMA and 20% had taken Amphetamine or Methamphetamine at least once.
Of the parents who were surveyed 88% said their biggest concern was relating to their children taking drugs and the accessibility of recreational substances, more than drinking alcohol and bullying.
Commenting on the survey was Hilary Bass. Her son Gary died after taking an ecstasy tablet containing PMA and as result she is campaigning for a “co-ordinated national approach to drugs education” and is asking the government to act quickly. She said “It is too late to save Gary, but it is not too late to save others.”
As part of our on-going dedication to those involved in child care issues, Trimega Laboratories have developed an innovative online system to simplify and expedite the process of facilitating instructions. Trimega on Demand allows users the option to reduce manual processing and have all instructions available to them immediately.
Registration to the site will take only minutes and will allow you to quickly request and approve quotations on-line. Following the acceptance of the quote the registered user will be able to view the ‘real-time’ status of all instructions.
All the information relating to your instruction will be available to view securely including chain of custody and photographs of donor. Reports will be available to you to view as soon as results are released by the laboratory.
Should you have any questions regarding the portal you can use our live chat facility on the site which will allow you to contact a member of our client services team immediately. In addition, all invoices and outstanding balances will be available online.
For those involved in testing clients for alcohol misuse its important that you have an understanding on how much is deemed to be excessive.
In the context of hair alcohol testing it is the World Health Organisation (WHO) guidelines which are of importance. Their guidance relates to the threshold of excessive consumption and determines if a person is an excessive drinker and should not be confused with government guidelines on “safe” amounts that can be consumed. WHO current guidelines are that if a person has an average consumption of 60 grams of alcohol per day over several months then this is indicative of excessive chronic alcohol consumption.
So the question is – how much is that in terms of units? The answer is that it equates to around 7.5 units per day. This is equivalent to around 4 pints of regular strength beer or 4 standard 175ml glasses of wine. More and more people are drinking at home. If wine is their tipple of choice then think of it as just shy of a bottle of wine. A bottle of wine generally will contain 9.5 units.
With regard to testing, its important to be aware that hair test results are based on a persons average level of consumption and behaviour for the specified period of time.
Has this whetted your appetite for further information? If so, Trimega Laboratories provide a range of CPD accredited training courses on hair alcohol, hair drug and DNA relationship testing to those involved with child care issues. Our courses are all complimentary and accredited by the Solicitors Regulation Authority and Bar Standards Board. To book a course please click here
There’s no way of breaking this gently – Christmas is 105 days away….and the end of the CPD training year is 51 days away.
As part of our on-going dedication to those involved in child care issues, Trimega Laboratories provide CPD accredited training courses on Hair Drug Testing, Hair Alcohol Testing and DNA Relationship Testing.
The courses are designed to provide delegates with further knowledge on the subject matters and assist in interpretation of results and will reaffirm why testing remains relevant to protecting vulnerable individuals.
The seminars are provided at no cost, with each being accredited by the Solicitors Regulation Authority and Bar Standards Board. They can be presented face-to-face for larger groups at a location suitable to you or at our head office in Manchester where the option of our laboratory facilities can be be provided. Alternatively they be held via telephone using a Live Internet based presentation.
For further information please contact 0845 388 0124 or click on our link
The government’s Advisory Council on the Misuse of Drugs (ACMD) have carried out a review on prescription medication. Based on this they have made the recommendation that three substances should be reclassified as controlled substances. The three substances this relates to are Lidexamfetamine, Zalepon and Zopiclone.
Lidexamfetamine is a stimulant that is used for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged over 6 years and young people. It treats the parts of the brain responsible for self-control and attention and has been found to improve activity in these areas helping the child with concentration and reduce impulsive behaviour. It is considered to be risk for misuse as it itself can be a addictive substance, and should only be prescribed by a doctor where its usage can be monitored. It can also easily be converted into and illegal amphetamine or methamphetamine.
Zalepon and Zopiclone are both treatments for insomnia. The ACMD considers them to carry risk of diversion and misuse and therefore should be controlled under the Misuse of Drugs Act as Class C substances.
At present these are only recommendations for the Home Office to consider. The final decision will be made in the coming weeks.
The Advisory Council on the Misuse of Drugs (ACMD) is an independent expert body that advises Government on drug-related issues in the UK. It was established under the Misuse of Drugs Act 1971 and chaired by Professor Les Iversen, a retired Oxford University professor of pharmacology and a specialist in neuropharmacology.